Research on Financial Performance Evaluation of Pharmaceutical Listed Companies: Based on Factor Analysis and Cluster Analysis

Qianqian Lu

doi:10.62051/2gmt4a59

Authors

Qianqian Lu

DOI:

https://doi.org/10.62051/2gmt4a59

Keywords:

pharmaceutical industry; financial performance evaluation; factor analysis; cluster analysis.

Abstract

With the improvement of people's living standards in China, people pay more and more attention to their own health. As one of the basic industries for people's livelihood, the pharmaceutical industry is often concerned. The article takes 85 pharmaceutical listed companies in China as the research object, selects 12 indicators from four aspects: profitability, debt paying ability, growth ability, and operational ability, and evaluates the financial performance of pharmaceutical listed companies based on factor analysis. By applying cluster analysis, 85 pharmaceutical listed companies were divided into 5 categories, providing more targeted and specific suggestions, creating conditions for the continuous optimization and development of pharmaceutical enterprises.

Downloads

Download data is not yet available.

References

[1] Chen Ruixue. Research on the influencing factors of stock returns in China's pharmaceutical industry. Tianjin: Tianjin University of Finance and Economics, 2018.

[2] Cao Xin, Ruan Xianjing. Research on the Evaluation of Innovation and Development Capability of Chinese Pharmaceutical Enterprises Based on Factor Analysis Method. Chinese Pharmacy, 2020, 31 (16): 1931-1937.

[3] Chen Lu, Pu Qiuyue, Qiu Yadong. Research on Financial Performance Evaluation of Pharmaceutical Listed Companies Based on Principal Component Analysis. China Collective Economy, 2022, 5: 147-148.

[4] Huang Rui. Research on the Financial Performance of HSL Pharmaceutical Company under the Background of the Epidemic. Beijing: North China University of Technology, 2022.